GlycanAge Champion 2026
Selected as GlycanAge Champion 2026

ExoEarth Corporation Representative Director Takashi Nishihira, aged 67 at the time of the award, was selected by GlycanAge as GlycanAge Champion 2026 – Immune Health Champion at the international event “Inflammaging in Clinical Practice 2026” in Dubrovnik, Croatia, on June 20, 2026.
Published Results
The results announced at the time of the award were as follows.
| Chronological Age at Sample Collection | GlycanAge Measurement Result | Age Gap | Percentile Rank |
|---|---|---|---|
| 66 years | 20 years | −46 years | Top 1% |
Note: This award and these measurements concern Takashi Nishihira's personal results and ongoing efforts. They do not demonstrate medical or rejuvenation effects of any particular product or service, or the outcomes of collaborative research.
What Is GlycanAge?
GlycanAge is a biological age test that analyzes glycan patterns of immunoglobulin G (IgG) in blood to capture characteristics associated with immune and inflammatory regulation and aging.
GlycanAge is informed by research including a study of 5,117 European participants, which identified IgG glycans as promising biomarkers of biological aging. Twin studies have also reported that GlycanAge indicators are not determined by genetics alone and can change with lifestyle and environmental factors.
GlycanAge is therefore used to measure IgG glycan-based indicators repeatedly and track changes in an individual's results.
Note: Please see Glycan Science for more detail.
Champion's Message
I am deeply honored to receive this award.
I regard this recognition not as my achievement alone, but as a shared achievement with the researchers, healthcare professionals, partner companies and everyone who has supported our activities over many years.
The world now faces the major challenge of rapid population aging.
Drawing on the experience and knowledge we have developed in Japan, we hope to offer new options in the pursuit of longer healthspans.
This award is not our destination.
I see it as a starting point for sharing a new longevity model from Japan with the world.
We envision an era in which people continually measure the body's condition, understand its changes, and pursue ongoing efforts to support long-term health.
By connecting science, data, AI and everyday practice, we will work to contribute to longer healthspans for people around the world.
(Takashi Nishihira, Representative Director, ExoEarth Corporation)
ExoEarth's Challenge
We do not view healthspan as simply living longer.
What matters is not only how long we live, but how long we remain healthy and active.
Through understanding health, ongoing observation, data use and consideration of options suited to each individual's condition, ExoEarth aims to help build a society in which people can continue to live in their own way.
We position this award as one individual example of those efforts in practice.

